Asahi Kasei Corporation

Asahi Kasei Corporation

AHKSY

$20.29

Updated: 24/09/2026, 07:03:38

Market Cap
$13.66B
Sector
Industrials
Industry
Conglomerates
Country
JP
Stock valuation chart
One-year closing share-price history for AHKSY
Company Profile

Asahi Kasei Corporation, a multinational enterprise established in Tokyo, Japan, in 1922, engages globally in the manufacturing, processing, and sale of a diverse array of products across three primary business segments: Material, Homes, and Health Care. Its expansive Material segment encompasses a broad spectrum of chemical products and functional materials. This includes foundational chemicals like caustic soda, nitric acid, ammonia, acrylonitrile, and styrene, as well as various chemical fertilizers, intermediates, polymers, and additives. The division also specializes in advanced membranes, optical and printing materials, electronic materials, and critical battery components, such as lithium-ion and lead-acid battery separators. Beyond chemicals, it produces high-performance fibers and textiles, offering products like cupro fiber, lining and stretch fabrics, a wide range of spunbond and specialty nonwovens (including deodorizing and heat-press formable types), microfiber suede, and nylon filaments. Further offerings in this segment extend to synthetic rubber, elastomers, household goods, cleaning products, packaging solutions, electronic devices, and construction materials such as autoclaved aerated concrete (AAC), foundation systems, insulation, and structural components. The Homes segment provides integrated residential solutions, spanning the construction of both houses and apartments, professional management for rental units and condominiums, and brokerage services for pre-owned properties. Additionally, this segment delivers remodeling services, mortgage financing, asset management, and insurance products tailored for homeowners. Finally, Asahi Kasei's Health Care segment is a key player in the medical field, developing and distributing pharmaceuticals and diagnostic reagents. It manufactures critical medical equipment, including dialyzers and therapeutic apheresis devices. The company also supplies advanced filtration products for biotherapeutics, plasma derivatives, virus removal, and leukocyte reduction. Complementing these are life-saving technologies like defibrillators, sophisticated temperature management systems, data solutions for healthcare applications, and innovative UVC LED products.

USD
OTC
CEO: Koshiro Kudo
Employees: 47,895
https://www.asahi-kasei.com
Asset Summaries
Latest generated summaries for AHKSY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for AHKSY.
Share price
$20.29
Market cap
$13.66B
Exchange
OTC
Currency
USD
CEO
Koshiro Kudo
Employees
47,895
IPO date
04/10/2007
Beta
0.652
Last dividend
$0.00
Day range
$20.24 – $20.66
52-week range
$15.18 – $24.12
1-day performance
-1.83%
1-year performance
33.66%
Current drawdown (1Y)
-15.88%
CIK
N/A
CUSIP
043400100
ISIN
US0434001006
Created
07/12/2025, 01:59:49
Last update
24/09/2026, 07:03:38

Track Asahi Kasei Corporation with an AI analyst

See which prediction-market events move AHKSY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to AHKSY from your Railway `news_articles` table.